Dear partners,

At Blessings International, our prayers go out to those who have been affected by COVID-19 (novel coronavirus) and to all those who are serving and attempting to find solutions to this virus. 

Our response to COVID-19 is to provide supportive care measures for the most marginalized and vulnerable patient populations by ensuring those who are serving are able to order and receive medicines and supplies as quickly and cost effectively as possible.
 
In an effort to assist with the treatment of COVID-19 symptoms, we want our partners to know we are able to ship directly to the country in need. Medicines such as acetaminophen, albuterol inhalers, and guaifenesin, as well as other supportive care medicines, are currently available. (To check the availability of other medications and medical supplies, please visit our online catalogue .)

For organizations connected with communities in developing nations but which are unable to go and serve directly, Blessings International is able to ship all products to those locations . For shipments that exceed $5,000, Blessings International will pay for shipping to the port of import. (For more information on our free shipping policy, please visit our website .)
 
As an organization, we are continuing to monitor COVID-19 and possible treatments. One potential treatment option that has been discussed in research literature and is continuing to be tested is chloroquine. Although chloroquine is typically associated with malaria treatment, COVID-19 appears to have a sensitivity to this older medication which Blessings International has provided to the international community for many years. Find more information on chloroquine as possible use against COVID-19 here

If supply of certain medicines or other items are temporarily affected for any order, be assured we will be in close communication with your team and will work toward finding an alternative item or resolution.

We appreciate your partnership, and consider ourselves fortunate to come alongside you in efforts to overcome COVID-19.
 Yours together in His service,
Barry Ewy, PharmD, JD, MHA
Chief Executive Officer

For the latest information on COVID-19, please refer to the World Health Organization (WHO) or the Center for Disease Control (CDC).